Skip to main content
Clinical Trials/IRCT2013121915863N1
IRCT2013121915863N1
Completed
Phase 2

Assesment of the effect of supplemental aqueous extracts of Achillea milefolium on the symptoms, severity and memory deficits in Rafsanjan Multiple sclerosis patients

Rafsanjan University of Medical Sciences0 sites75 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Rafsanjan University of Medical Sciences
Enrollment
75
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria were an age of 16 to 55 years; a diagnosis of multiple sclerosis, according to the revised McDonald criteria; a relapsing–remitting course; one or more documented relapses in the previous year or two or more in the previous 2 years; and a score of 0 to 5\.5 on the EDSS. exclusion criteria were relapse or corticosteroid treatment within 30 days before randomization, active infection, or clinically significant systemic disease.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials